0001104659-24-058588.txt : 20240508
0001104659-24-058588.hdr.sgml : 20240508
20240508133827
ACCESSION NUMBER: 0001104659-24-058588
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20240331
FILED AS OF DATE: 20240508
DATE AS OF CHANGE: 20240508
EFFECTIVENESS DATE: 20240508
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: RiverVest Venture Management LLC
CENTRAL INDEX KEY: 0001812549
ORGANIZATION NAME:
IRS NUMBER: 431900629
STATE OF INCORPORATION: MO
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-21321
FILM NUMBER: 24925189
BUSINESS ADDRESS:
STREET 1: 101 S. HANLEY ROAD
STREET 2: SUITE 1850
CITY: ST. LOUIS
STATE: MO
ZIP: 63105
BUSINESS PHONE: 314-726-6700
MAIL ADDRESS:
STREET 1: 101 S. HANLEY ROAD
STREET 2: SUITE 1850
CITY: ST. LOUIS
STATE: MO
ZIP: 63105
13F-HR
1
primary_doc.xml
X0202
13F-HR
LIVE
false
false
false
0001812549
XXXXXXXX
03-31-2024
03-31-2024
false
RiverVest Venture Management LLC
101 S. Hanley Road
Suite 1850
St. Louis
MO
63105
13F HOLDINGS REPORT
028-21321
N
Sivan Weitzman
Chief Financial Officer
314-726-6700
/s/ Sivan Weitzman
St. Louis
MO
02-12-2024
0
4
8141025
INFORMATION TABLE
2
infotable.xml
Spruce Bioscience, Inc.
Common
85209E109
2307624
2936281
SH
SOLE
2936281
0
0
Vapotherm, Inc.
Common
922107107
69806
52881
SH
OTR
0
52881
0
Reneo Pharmaceuticals, Inc.
Common
75974E103
4206805
2534220
SH
SOLE
2534220
0
0
Xilio Therapeutics, Inc.
Common
98422T100
1556790
1441444
SH
SOLE
1441444
0
0